| (210) | Number of the EPO application | 16778038 |
| (220) | Filing date of the EPO application | 2016.10.07 |
| (80) | EPO patent specification publication (B) | EPB nr. 11/2021, 2021.03.17 |
| (110) | EPO patent number | 3359542 |
| (21) | Number of the application | e 2018 0787 |
| (71) | Name(s) of applicant(s), code of the country | Boehringer Ingelheim International GmbH, DE; |
| (72) | Name(s) of inventor(s), code of the country | GOLLNER Andreas, DE;
BROEKER Joachim, DE;
KERRES Nina, DE;
KOFINK Christiane, DE;
RAMHARTER Juergen, DE;
WEINSTABL Harald, DE;
GILLE Annika, DE;
GOEPPER Stefan, DE;
HENRY Manuel, DE;
HUCHLER Guenther, DE; |
| (73) | Name(s) of owner(s), code of the country | BOEHRINGER Ingelheim International GmbH, DE; |
| (54) | Title of the invention | SPIRO[3H-INDOLE-3,2´-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 471/22 (2006.01.01); C07D 487/22 (2006.01.01); A61K 31/438 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | DE |
| (41) | Date of publication of the application | 2018.09.30 |
| (30) | Priority | 15189210, 2015.10.09, EP |
| (86) | International application | PCT/EP2016/074008, 2016.10.07 |
| (87) | International publication | WO 2017/060431, 2017.04.13 |